Magnetic resonance imaging findings of the lower limb muscles in anti-mitochondrial M2 antibody-positive myositis

Neuromuscul Disord. 2023 Sep;33(9):74-80. doi: 10.1016/j.nmd.2023.07.005. Epub 2023 Jul 25.

Abstract

Anti-mitochondrial M2 antibody (AMA-M2)-positive myositis is an idiopathic inflammatory myopathy (IIM). Of all patients with myositis, 2.5-19.5% have AMA-M2 antibodies. However, the detailed distribution of muscles affected in AMA-positive myositis is unknown. Therefore, we examined lower muscle magnetic resonance imaging (MRI) findings of patients with AMA-positive myositis. Among the 63 patients with IIM at our institute, 5 (7.9%) were positive for AMA-M2 antibodies. However, one was also positive for anti-Jo1 antibodies; therefore, four patients were finally participated in this study. All patients had high-intensity MRI signals in the proximal muscles, including the gluteus maximus and iliopsoas muscles, and in the thigh muscles, including the vastus lateralis, vastus medialis, adductor magnus, and semimembranosus muscles. Lower leg muscles were relatively spared. Fascial edema was observed in all patients and was also present in the lower leg muscles. Subcutaneous edema was observed, particularly in the proximal portion of the lower limbs. In AMA-positive myositis, proximal muscles, including the gluteus maximus, vastus lateralis, adductor magnus, and the semimembranosus, were markedly affected, while the lower leg muscles were relatively preserved. Additionally, fascial edema was evident even in lower leg muscles. Therefore, muscle MRI can be a useful diagnostic aid for AMA-positive myositis.

Keywords: Anti-mitochondrial antibody-positive myositis; Fascial edema; Idiopathic inflammatory myopathy; Muscle MRI; Subcutaneous edema.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies
  • Humans
  • Leg
  • Lower Extremity* / diagnostic imaging
  • Magnetic Resonance Imaging
  • Myositis* / diagnostic imaging
  • Quadriceps Muscle

Substances

  • Antibodies